Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Hiding in plain view: the potential for commonly used drugs to reduce breast cancer mortality.

Holmes MD, Chen WY.

Breast Cancer Res. 2012 Dec 10;14(6):216. doi: 10.1186/bcr3336. Review.

2.

Beyond aspirin-cancer prevention with statins, metformin and bisphosphonates.

Gronich N, Rennert G.

Nat Rev Clin Oncol. 2013 Nov;10(11):625-42. doi: 10.1038/nrclinonc.2013.169. Epub 2013 Oct 1. Review.

PMID:
24080598
3.

Effect of combinations of drugs on all cause mortality in patients with ischaemic heart disease: nested case-control analysis.

Hippisley-Cox J, Coupland C.

BMJ. 2005 May 7;330(7499):1059-63. Erratum in: BMJ. 2006 Apr 15;332(7546):912.

4.

Evidence-based use of medications in patients with coronary artery disease in a rural Australian community.

Granmyr J, Ball P, Curran S, Wang L.

Aust J Rural Health. 2007 Aug;15(4):241-6.

PMID:
17617087
5.

Blind Snipers: Relevant Off Target Effects of Non-chemotherapeutic Agents in Oncology: Review of the Literature.

Prochilo T, Di Biasi B, Aroldi F, Bertocchi P, Sabatini T, Meriggi F, Zaniboni A.

Rev Recent Clin Trials. 2014;9(2):102-14. Review.

PMID:
24854040
6.

Beta blockers and angiotensin-converting enzyme inhibitors' purported benefit on breast cancer survival may be explained by aspirin use.

Holmes MD, Hankinson SE, Feskanich D, Chen WY.

Breast Cancer Res Treat. 2013 Jun;139(2):507-13. doi: 10.1007/s10549-013-2553-7. Epub 2013 May 7.

7.

The Role of Aspirin, Vitamin D, Exercise, Diet, Statins, and Metformin in the Prevention and Treatment of Colorectal Cancer.

Sehdev A, O'Neil BH.

Curr Treat Options Oncol. 2015 Sep;16(9):43. doi: 10.1007/s11864-015-0359-z. Review.

PMID:
26187794
8.

Adjunctive pharmacologic use in carotid endarterectomy: a review.

Gortler D, Maloney S, Rutland R, Westvik T, Muto A, Kudo FA, Dardik A.

Vascular. 2006 Mar-Apr;14(2):93-102. Review.

PMID:
16956478
9.

Use and cost of branded and generic drugs in patients with coronary heart disease--results from a prospective survey of 1008 patients in two London hospitals.

Corp EV, Antoniou S, Wright PG, Khachi H, Vercaeren S, Wald DS.

QJM. 2009 Dec;102(12):843-9. doi: 10.1093/qjmed/hcp127. Epub 2009 Oct 14.

10.
11.

Common cardiovascular medications in cancer therapeutics.

Vaklavas C, Chatzizisis YS, Tsimberidou AM.

Pharmacol Ther. 2011 May;130(2):177-90. doi: 10.1016/j.pharmthera.2011.01.009. Epub 2011 Jan 26. Review.

PMID:
21277894
12.

Self-reported use of evidence-based medicine and smoking cessation 6 - 9 months after acute coronary syndrome: a single-centre perspective.

Griffiths B, Lesosky M, Ntsekhe M.

S Afr Med J. 2014 Jun 17;104(7):483-7. doi: 10.7196/samj.7798.

PMID:
25214049
13.

Cost-effectiveness of optimal use of acute myocardial infarction treatments and impact on coronary heart disease mortality in China.

Wang M, Moran AE, Liu J, Coxson PG, Heidenreich PA, Gu D, He J, Goldman L, Zhao D.

Circ Cardiovasc Qual Outcomes. 2014 Jan;7(1):78-85. doi: 10.1161/CIRCOUTCOMES.113.000674. Epub 2014 Jan 14.

15.

Long-term adherence with cardiovascular drug regimens.

Kulkarni SP, Alexander KP, Lytle B, Heiss G, Peterson ED.

Am Heart J. 2006 Jan;151(1):185-91.

PMID:
16368315
16.

Evaluation of preventive cardiovascular pharmacotherapy after coronary artery bypass graft surgery.

Barry AR, Koshman SL, Norris CM, Ross DB, Pearson GJ.

Pharmacotherapy. 2014 May;34(5):464-72.

PMID:
24877186
17.

Low use of statins and other coronary secondary prevention therapies in primary and secondary care in India.

Sharma KK, Gupta R, Agrawal A, Roy S, Kasliwal A, Bana A, Tongia RK, Deedwania PC.

Vasc Health Risk Manag. 2009;5:1007-14. Epub 2009 Nov 23.

18.

C-reactive protein (CRP)-lowering agents.

Prasad K.

Cardiovasc Drug Rev. 2006 Spring;24(1):33-50. Review.

PMID:
16939632
19.

Reduced risk of breast cancer recurrence in patients using ACE inhibitors, ARBs, and/or statins.

Chae YK, Valsecchi ME, Kim J, Bianchi AL, Khemasuwan D, Desai A, Tester W.

Cancer Invest. 2011 Nov;29(9):585-93. doi: 10.3109/07357907.2011.616252. Epub 2011 Sep 21.

PMID:
21936625
20.

Treatment of type 2 diabetes and outcomes in patients with heart failure: a nested case-control study from the U.K. General Practice Research Database.

MacDonald MR, Eurich DT, Majumdar SR, Lewsey JD, Bhagra S, Jhund PS, Petrie MC, McMurray JJ, Petrie JR, McAlister FA.

Diabetes Care. 2010 Jun;33(6):1213-8. doi: 10.2337/dc09-2227. Epub 2010 Mar 18.

Items per page

Supplemental Content

Write to the Help Desk